Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Safety, efficacy, and immunogenicity of a replication-defective human cytomegalovirus vaccine, V160, in cytomegalovirus-seronegative women: a double-blind, randomised, placebo-controlled, phase 2b trial
Rituparna Das, Daniel Blázquez‐Gamero, David I. Bernstein, et al.
The Lancet Infectious Diseases (2023) Vol. 23, Iss. 12, pp. 1383-1394
Closed Access | Times Cited: 26

Showing 1-25 of 26 citing articles:

Safety and Immunogenicity of a Messenger RNA–Based Cytomegalovirus Vaccine in Healthy Adults: Results From a Phase 1 Randomized Clinical Trial
Carlos Fierro, Daniel C. Brune, Marian Shaw, et al.
The Journal of Infectious Diseases (2024) Vol. 230, Iss. 3, pp. e668-e678
Open Access | Times Cited: 18
The mRNA-1647 vaccine: A promising step toward the prevention of cytomegalovirus infection (CMV)
Adewunmi Akingbola, Abiodun Adegbesan, Olajumoke Adewole, et al.
Human Vaccines & Immunotherapeutics (2025) Vol. 21, Iss. 1
Open Access | Times Cited: 2
Human Cytomegalovirus (HCMV) Genetic Diversity, Drug Resistance Testing and Prevalence of the Resistance Mutations: A Literature Review
Ivana Grgić, Lana Gorenec
Tropical Medicine and Infectious Disease (2024) Vol. 9, Iss. 2, pp. 49-49
Open Access | Times Cited: 8
A vaccine against cytomegalovirus: how close are we?
Sallie R. Permar, Mark R. Schleiss, S. A. Plotkin
Journal of Clinical Investigation (2025) Vol. 135, Iss. 1
Closed Access | Times Cited: 1
Mucosal T-cell responses to chronic viral infections: Implications for vaccine design
Mohammed Al‐Talib, Sandra Dimonte, Ian R. Humphreys
Cellular and Molecular Immunology (2024) Vol. 21, Iss. 9, pp. 982-998
Open Access | Times Cited: 8
Lessons from Acquired Natural Immunity and Clinical Trials to Inform Next-Generation Human Cytomegalovirus Vaccine Development
Xintao Hu, Hsuan-Yuan Wang, Claire E. Otero, et al.
Annual Review of Virology (2022) Vol. 9, Iss. 1, pp. 491-520
Open Access | Times Cited: 22
Proceedings of the Conference “CMV Vaccine Development—How Close Are We?” (27–28 September 2023)
Mark R. Schleiss, Chelsea M. Crooks, Krithika P. Karthigeyan, et al.
Vaccines (2024) Vol. 12, Iss. 11, pp. 1231-1231
Open Access | Times Cited: 4
Prevalence of Ocular and Visual Abnormalities Following Symptomatic and Asymptomatic Congenital CMV Infection: A Systematic Review and Meta-Analysis
Tamar Schrieber, Naomi Tan, Alice Bellchambers, et al.
(2025)
Closed Access
Human cytomegalovirus gH/gL/gO binding to PDGFRα provides a regulatory signal activating the fusion protein gB that can be blocked by neutralizing antibodies.
Eric P. Schultz, Lars Ponsness, Jean-Marc Lanchy, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2025)
Open Access
Vaccine Based Approaches for the Prevention and Treatment of Neurological Disease
Nicholas Aderinto, Israel Charles Abraham, Gbolahan Olatunji, et al.
Current Treatment Options in Neurology (2025) Vol. 27, Iss. 1
Closed Access
L’infection à cytomégalovirus chez la femme enceinte, recommandations à l’officine
Anne-Solène Naudon
Actualités Pharmaceutiques (2025) Vol. 64, Iss. 644, pp. 47-50
Closed Access
The Fight Continues: Virus Without Vaccines
Van G. Wilson
(2025), pp. 373-391
Closed Access
Human cytomegalovirus gH/gL/gO binding to PDGFRα provides a regulatory signal activating the fusion protein gB that can be blocked by neutralizing antibodies
Eric P. Schultz, Lars Ponsness, Jean-Marc Lanchy, et al.
Journal of Virology (2025)
Open Access
Developing a Vaccine Against Human Cytomegalovirus: Identifying and Targeting HCMV’s Immunological Achilles’ Heel
Anastasia Lankina, Marta Brezmes Raposo, Alexander Hargreaves, et al.
Vaccines (2025) Vol. 13, Iss. 5, pp. 435-435
Open Access
Safety, Tolerability, and Immunogenicity of V160, a Conditionally Replication-Defective Cytomegalovirus Vaccine, in Healthy Japanese Men in a Randomized, Controlled Phase 1 Study
Shinya Murata, Nobuyuki Oshima, Takashi Iwasa, et al.
Antibodies (2023) Vol. 12, Iss. 1, pp. 22-22
Open Access | Times Cited: 7
Transcriptional signature of durable effector T cells elicited by a replication defective HCMV vaccine
Xiaohua Ye, David Shih, Zhiqiang Ku, et al.
npj Vaccines (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 2
Burden of Congenital CMV Infection: A Narrative Review and Implications for Public Health Interventions
Cecilia Liberati, Giulia Sturniolo, Giulia Brigadoi, et al.
Viruses (2024) Vol. 16, Iss. 8, pp. 1311-1311
Open Access | Times Cited: 2
Human cytomegalovirus: pathogenesis, prevention, and treatment
Zifang Shang, Xin Li
Molecular Biomedicine (2024) Vol. 5, Iss. 1
Open Access | Times Cited: 2
The quest for a cytomegalovirus vaccine continues
Flavia Chiuppesi, Felix Wussow
The Lancet Infectious Diseases (2023) Vol. 23, Iss. 12, pp. 1330-1332
Closed Access | Times Cited: 5
Structure-Guided Mutagenesis Targeting Interactions between pp150 Tegument Protein and Small Capsid Protein Identify Five Lethal and Two Live-Attenuated HCMV Mutants
Alexander Stevens, Ruth Cruz‐Cosme, Najealicka Armstrong, et al.
Virology (2024) Vol. 596, pp. 110115-110115
Open Access | Times Cited: 1
Spatial kinetics and immune control of murine cytomegalovirus infection in the salivary glands
Catherine Byrne, Ana Márquez, Bing Cai, et al.
PLoS Computational Biology (2024) Vol. 20, Iss. 8, pp. e1011940-e1011940
Open Access | Times Cited: 1
Prenatal and postnatal antiviral therapies for the prevention and treatment of congenital cytomegalovirus infections
Preethi Chandrasekaran, Han‐Shin Lee, Lisa Hui, et al.
Current Opinion in Infectious Diseases (2024) Vol. 37, Iss. 6, pp. 494-505
Closed Access | Times Cited: 1
Relationship of human cytomegalovirus‐infected endothelial cells and circulating leukocytes in the pathogenesis of disseminated human cytomegalovirus infection: A narrative review
Giuseppe Gerna, Daniele Lilleri, Chiara Fornara, et al.
Reviews in Medical Virology (2023) Vol. 34, Iss. 1
Open Access | Times Cited: 3
Spatial kinetics and immune control of murine cytomegalovirus infection in the salivary glands
Catherine Byrne, Ana Márquez, Bing Cai, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Current evidence gaps to support systematic cytomegalovirus screening in pregnancy
Agathe Billette De Villemeur, B Hoen, Éric Billaud, et al.
EClinicalMedicine (2024) Vol. 78, pp. 102941-102941
Open Access
Page 1 - Next Page

Scroll to top